BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1835361)

  • 41. Carotid artery atherosclerotic disease assessed by flow velocity wave form analysis in hemodialyzed normotensive and hypertensive patients.
    Bernardi D; Ferreri A; Moretti P; Nesti E; Urti DA; Bonechi I
    Nephron; 1986; 44(3):180-5. PubMed ID: 3537816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension.
    Cesena FHY; Nary FC; Santos RD; Bittencourt MS
    J Clin Hypertens (Greenwich); 2020 Jul; 22(7):1192-1199. PubMed ID: 32558248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis.
    Savazzi GM; Cusmano F; Musini S
    Nephron; 2001 Sep; 89(1):31-6. PubMed ID: 11528229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolated systolic hypertension in the community. Data from a population survey and hypertension register in Northern Italy.
    Ambrosio GB; Zamboni S; Pilotto L; Dal Palù C
    Clin Exp Hypertens A; 1982; 4(7):1133-50. PubMed ID: 6981470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of systolic blood pressure in determining prognosis of hemodialyzed patients.
    Tomita J; Kimura G; Inoue T; Inenaga T; Sanai T; Kawano Y; Nakamura S; Baba S; Matsuoka H; Omae T
    Am J Kidney Dis; 1995 Mar; 25(3):405-12. PubMed ID: 7872317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of malignant hypertension in patients with uremia under hemodialysis: a case report and discussions on its etiology.
    Kaneda H; Murata T; Maeta T; Matsumoto J; Shitomi K; Haruyama T; Hara M; Wakasa H
    Tohoku J Exp Med; 1981 Nov; 135(3):291-9. PubMed ID: 7031989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and Trends of Isolated Systolic Hypertension among Korean Adults: the Korea National Health and Nutrition Examination Survey, 1998-2012.
    Kim NR; Kim HC
    Korean Circ J; 2015 Nov; 45(6):492-9. PubMed ID: 26617652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the evidence for accelerated atherogenesis in uremia?
    Kettner A; Ritz E
    Int J Artif Organs; 1982 Jul; 5(4):228-9. PubMed ID: 7118284
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients.
    Savazzi GM; Cusmano F; Bergamaschi E; Vinci S; Allegri L; Garini G
    Nephron; 1999 Jan; 81(1):17-24. PubMed ID: 9884414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudohypertension in hemodialyzed arteriosclerotic patients.
    Kuriyama S; Tomonari H; Utsunomiya Y; Kinoshita N; Matsumoto H
    Nephron; 1994; 66(4):479-80. PubMed ID: 8015657
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hypertension in the aged: (1) Prevalence and complications].
    Hirota Y
    Nihon Ronen Igakkai Zasshi; 1975 Jul; 12(4):218-21. PubMed ID: 1238771
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of hemodialysis combined with hemofiltration in the treatment of uremia complicated with intractable hypertension.
    Xu T; Wang D; Cong G
    Am J Transl Res; 2023; 15(5):3521-3529. PubMed ID: 37303622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Harte JD: Hypertension in the elderly.
    Miller RG
    Gerontol Clin (Basel); 1967; 9(3):167-75. PubMed ID: 6055297
    [No Abstract]   [Full Text] [Related]  

  • 54. [Age and arterial hypertension in hemodialysis patients].
    Marinac D; Josipović J; Pavlović D
    Acta Med Croatica; 2012 Jul; 66(3):165-71. PubMed ID: 23441530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
    Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
    Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ambulatory blood pressure profile during 48 hours in patients treated with chronic hemodialysis].
    Battistella P; de Cornelissen F; de Gaudemaris R; Contard S; Janin G
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1223-7. PubMed ID: 2124459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
    Lebel M; Kingma I; Grose JH; Langlois S
    Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Isolated systolic hypertension in uremic hemodialyzed patients].
    Simon P; Ang KS; Benziane A; Cam G
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1205-10. PubMed ID: 1835361
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.